TipRanks
Advertisement

RINT - ETF AI Analysis

Compare

Top Page

RINT

International Developed Equity Active ETF (RINT)

Rating:65Neutral
Price Target:―
RINT’s rating suggests it is a solid but not top-tier ETF, with its quality driven by strong holdings like TSM and HSBC, which benefit from robust financial performance, positive earnings sentiment, and strategic positioning in advanced technologies and global banking. Healthcare names such as AstraZeneca and Roche also support the fund through strong pipelines and strategic initiatives, though their higher valuations and some overvaluation signals, along with bearish or mixed technical trends in holdings like Schneider Electric and Shell, modestly weigh on the overall rating. The main risk is that several key holdings show signs of being expensive or facing short-term technical weakness, which could increase volatility if market conditions turn less favorable.
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and in recent months, indicating positive momentum.
Global Diversification Across Developed Markets
Holdings spread across countries like Japan, the U.S., the UK, France, and Germany help reduce the impact of weakness in any single market.
Leading Global Companies in Top Holdings
The fund’s largest positions include several well-known, strong-performing global firms in technology, energy, financials, and health care, which support overall returns.
Negative Factors
Moderately High Expense Ratio
The fund’s fee is higher than many low-cost index ETFs, which can slightly reduce long-term net returns for investors.
Concentrated Exposure to Financials and General Industries
A sizable allocation to financial and broad “general” sectors means the fund could be more sensitive if these areas face pressure.
Mixed Health Care Performance
Some major health care holdings, such as AstraZeneca, have shown weaker recent performance, which can weigh on the fund’s results if the trend continues.

RINT vs. SPDR S&P 500 ETF (SPY)

RINT Summary

RINT is an actively managed ETF that invests in stocks from developed countries outside the U.S., giving you broad international exposure rather than tracking a single index. It holds well-known global companies like ASML Holding and Shell, spread across many sectors such as financials, industrials, technology, and health care. An investor might consider RINT to diversify a U.S.-heavy portfolio and tap into long-term growth in markets like Japan, the UK, and Europe. A key risk is that international stock prices can be volatile and move with global markets and currencies, so the value of this ETF can go up and down.
How much will it cost me?This ETF has an expense ratio of 0.49%, which means you’ll pay about $4.90 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed, with professionals selecting and adjusting the fund’s holdings instead of simply tracking an index.
What would affect this ETF?This ETF could benefit if developed markets outside the U.S. grow steadily, especially in financials, industrials, and global technology leaders like ASML and TSMC, and if international stocks come back into favor as investors look to diversify beyond the U.S. It could face challenges from global slowdowns, banking or energy sector stress, stronger regulations or taxes in Europe and other regions, or rising interest rates that hurt stock prices in its major markets.

RINT Top 10 Holdings

RINT is leaning heavily on global semiconductors, with ASML, TSMC, and Tokyo Electron acting as the fund’s main growth engines, all rising on the back of strong demand for advanced chips and AI-related hardware. Energy exposure via Shell adds a steady, cash-generating ballast. On the other side of the ledger, big European banks like UBS and HSBC have been more mixed, occasionally losing steam and dampening momentum. Health care names such as Roche, AstraZeneca, and GSK are treading water, leaving this developed-markets ex-U.S. ETF driven largely by its tech and energy bets.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV2.77%$3.86M€611.79B91.13%
76
Outperform
TSMC1.65%$2.30M$2.07T61.52%
81
Outperform
UBS Group AG1.32%$1.84M$145.64B21.11%
73
Outperform
HSBC Holdings1.15%$1.60M£239.17B40.44%
80
Outperform
Tokyo Electron1.05%$1.47M¥28.96T107.16%
73
Outperform
Schneider Electric0.97%$1.35M€150.44B7.90%
62
Neutral
Shell (UK)0.96%$1.34M£216.18B40.71%
73
Outperform
Roche Holding AG0.93%$1.30M$344.30B21.61%
73
Outperform
AstraZeneca0.89%$1.24M$246.54B-6.13%
80
Outperform
GlaxoSmithKline0.87%$1.21M£74.86B7.69%
77
Outperform

RINT Technical Analysis

Technical Analysis Sentiment
Negative
Last Price―
Price Trends
50DMA
32.71
Negative
100DMA
32.26
Negative
200DMA
31.31
Positive
Market Momentum
MACD
-0.24
Positive
RSI
42.04
Neutral
STOCH
34.43
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RINT, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 32.21, equal to the 50-day MA of 32.71, and equal to the 200-day MA of 31.31, indicating a neutral trend. The MACD of -0.24 indicates Positive momentum. The RSI at 42.04 is Neutral, neither overbought nor oversold. The STOCH value of 34.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RINT.

RINT Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$155.86M0.49%
65
Neutral
――$726.60M0.59%
62
Neutral
――$555.43M0.65%
64
Neutral
――$359.38M0.23%
65
Neutral
――$228.56M0.29%
70
Outperform
――$228.33M0.30%
62
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RINT
International Developed Equity Active ETF
31.86
4.23
15.31%
FYLD
Cambria Foreign Shareholder Yield ETF
―
―
―
TXUE
Thornburg International Equity ETF
―
―
―
AVSD
Avantis Responsible International Equity ETF
―
―
―
NBIE
Neuberger International Core Equity ETF
―
―
―
DXIV
Dimensional International Vector Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement